ABBV vs REGN
AbbVie vs Regeneron Pharmaceuticals — AI-powered side-by-side comparison
| Metric | ABBV | REGN |
|---|---|---|
| AI Score | 52 | 63 |
| Price | $254.38 | $679.08 |
| P/E Ratio | 119.75× | 15.80× |
| ROE | -1.3% | 14.3% |
| Revenue Growth YoY | — | 5.9% |
| Gross Margin | 0.7% | 85.7% |
| Debt / Equity | 2.65× | 0.09× |
| Dividend Yield | 0.0% | 0.6% |
| RSI (14) | 44.6 | 62.3 |
| Beta | 0.283 | 0.2076 |
| Expected Upside | +0.2% | +12.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ABBV Full Analysis
REGN Full Analysis